Memantine reduces stealing behavior and impulsivity in kleptomania: A pilot study

International Clinical Psychopharmacology

Volumn 28, Issue 2, 2013, Pages 106-111

  Grant, Jon E ^a   Odlaug, Brian L ^a,c   Schreiber, Liana R N ^b   Chamberlain, Samuel R ^d   Won Kim, Suck ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

impulse control disorder; kleptomania; psychopharmacology; treatment

Indexed keywords

MEMANTINE;

ADULT; AGED; ANXIETY; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITION; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY SEVERITY; DISEASE ASSOCIATION; DIZZINESS; DRUG DEPENDENCE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HAMILTON ANXIETY SCALE; HEADACHE; HUMAN; IMPULSIVENESS; INCREASED APPETITE; KLEPTOMANIA; MALE; MOOD; NAUSEA; OBSERVATIONAL STUDY; PILOT STUDY; PRIORITY JOURNAL; SCORING SYSTEM; THEFT; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VALIDATION STUDY; XEROSTOMIA;

ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG MONITORING; DRUG RESISTANCE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; IMPULSIVE BEHAVIOR; INTENTION TO TREAT ANALYSIS; LOST TO FOLLOW-UP; MALE; MEMANTINE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, N-METHYL-D-ASPARTATE; RISK-TAKING; THEFT; YOUNG ADULT;

EID: 84873409456     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e32835c8c8c     Document Type: Article

References (31)

1. Aboujaoude E, Gamel N, Koran LM (2004). Overview of kleptomania and phenomenological description of 40 patients. Prim Care Companion J Clin Psychiatry 6:244-247.
2. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association.
3. Bisaga A, Evans SM (2004). Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacology (Berl) 172:16-24.
4. Cohen S, Kamarck T, Mermelstein R (1983). A global measure of perceived stress. J Health Soc Behav 24:385-396.
5. Evans SM, Levin FR, Brooks DJ, Garawi F (2007). A pilot double-blind treatment trial of memantine for alcohol dependence. Alcohol Clin Exp Res 31: 775-782.
6. Frisch MB, Cornell J, Villaneuva M (1993). Clinical validation of the Quality of Life Inventory: a measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assess 4:92-101.
7. First MB, Spitzer RL, Gibbon M, Williams JBW (1995). Structured clinical interview for DSM-IV-patient edition (SCID-I/P, version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.
8. Grant JE, Kim SW (2002a). Clinical characteristics and associated psycho-pathology of 22 patients with kleptomania. Compr Psychiatry 43:378-384.
9. Grant JE, Kim SW (2002b). An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry 63:349-356.
10. Grant JE, Potenza MN (2008). Gender-related differences in individuals seeking treatment for kleptomania. CNS Spectr 13:235-245.
11. Grant JE, Levine L, Kim D, Potenza MN. (2005). Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 162:2184-2188.
12. Grant JE, Kim SW, McCabe JS (2006). A structured clinical interview for kleptomania (SCI-K): preliminary validity and reliability testing. Int J Methods Psychiatr Res 15:83-94.
13. Grant JE, Odlaug BL, Wozniak JR (2007). Neuropsychological functioning in kleptomania. Behav Res Ther 45:1663-1670.
14. Grant JE, Kim SW, Odlaug BL (2009). A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry 65:600-606.
15. Grant JE, Chamberlain SR, Odlaug BL, Potenza MN, Kim SW (2010). Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl) 212: 603-612.
16. Grant JE, Potenza MN, Krishnan-Sarin S, Cavallo DA, Desai RA (2011). Stealing among high school students: prevalence and clinical correlates. J Am Acad Psychiatry Law 39:44-52.
17. Grant JE, Odlaug BL, Mooney M, O'Brien R, Kim SW (2012). Open-label pilot study of memantine in the treatment of compulsive buying. Ann Clin Psychiatry 24:119-126.
18. Guy W (1976). ECDEU assessment manual for psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Healthpp. 218-222.
19. Hamilton M (1959). The assessment of anxiety states by rating. Br J Med Psychiatry 32:50-55.
20. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
21. Hölter SM, Danysz W, Spanagel R (1996). Evidence for alcohol anti-craving properties of memantine. Eur J Pharmacol 314:R1-R2.
22. Koran LM, Aboujaoude EN, Gamel NN (2007). Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. J Clin Psychiatry 68:422-427.
23. Krupitsky EM, Neznanova O, Masalov D, Burakov AM, Didenko T, Romanova T, et al. (2007). Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. Am J Psychiatry 164: 519-523.
24. Krystal JH, Petrakis IL, Krupitsky E, Schutz C, Trevisan L, D'Souza DC (2003). NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann N Y Acad Sci 1003:176-184.
25. Ma YY, Cepeda C, Cui CL (2009). The role of NMDA receptors in drug addiction. Int Rev Neurobiol 89:131-146.
26. McElroy SL, Pope HG Jr, Hudson JI, Keck PE Jr, White KL (1991). Kleptomania: a report of 20 cases. Am J Psychiatry 148:652-657.
27. Meisner F, Scheller C, Kneitz S, Sopper S, Neuren-Jacob E, Riederer P, et al. (2008). Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33:2228-2236.
28. Odlaug BL, Grant JE, Kim SW (2012). Suicide attempts in 107 adolescents and adults with kleptomania. Arch Suicide Res 16:348-359.
29. Sheehan DV (1983). The anxiety disease. New York: Scribner.
30. Spanagel R, Zieglgänsberger W (1997). Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54-59.
31. Wilde MI, Wagstaff AJ (1997). Acamprosate: a review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs 53:1038-1053.